chr10-18539365-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_201596.3(CACNB2):c.1624C>T(p.Arg542Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R542H) has been classified as Likely benign.
Frequency
Consequence
NM_201596.3 missense
Scores
Clinical Significance
Conservation
Publications
- Brugada syndrome 4Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- short QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNB2 | NM_201596.3 | MANE Select | c.1624C>T | p.Arg542Cys | missense | Exon 14 of 14 | NP_963890.2 | ||
| CACNB2 | NM_201590.3 | MANE Plus Clinical | c.1462C>T | p.Arg488Cys | missense | Exon 13 of 13 | NP_963884.2 | ||
| CACNB2 | NM_201597.3 | c.1552C>T | p.Arg518Cys | missense | Exon 14 of 14 | NP_963891.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNB2 | ENST00000324631.13 | TSL:1 MANE Select | c.1624C>T | p.Arg542Cys | missense | Exon 14 of 14 | ENSP00000320025.8 | ||
| CACNB2 | ENST00000377329.10 | TSL:1 MANE Plus Clinical | c.1462C>T | p.Arg488Cys | missense | Exon 13 of 13 | ENSP00000366546.4 | ||
| CACNB2 | ENST00000352115.10 | TSL:1 | c.1552C>T | p.Arg518Cys | missense | Exon 14 of 14 | ENSP00000344474.6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251302 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Brugada syndrome 4 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CACNB2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with cysteine at codon 488 of the CACNB2 protein (p.Arg488Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at